Characterization of tumor relevant isocitrate dehydrogenase 1 (IDH1)

被引:0
|
作者
Coleman, Nalani J. [1 ]
Thornberg, Ella [1 ]
Caliger, Danielle [1 ]
Luna, Lucas [1 ]
Sohl, Christal D. [1 ]
机构
[1] San Diego State Univ, San Diego, CA 92182 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1158/1538-7445.AM2020-3732
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3732
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Non-small cell lung cancers with isocitrate dehydrogenase 1 or 2 (IDH1/2) mutations
    Toth, Laura N.
    de Abreu, Francine B.
    Tafe, Laura J.
    HUMAN PATHOLOGY, 2018, 78 : 138 - 143
  • [42] Isocitrate dehydrogenase 1 (IDH1) driven Intrahepatic Cholangiocarcinoma (IHCC): A Comprehensive Genomic Profiling (CGP) Study
    Hemmerich, Amanda
    Killian, J. Keith
    Lechpammer, Mirna
    Lin, Douglas
    Danziger, Natalie
    Huang, Richard
    Decker, Brennan
    Janovitz, Tyler
    Mata, Douglas
    Elvin, Julia
    Ramkissoon, Shakti
    McGregor, Kimberly
    Ross, Jeffrey
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 970 - 971
  • [43] A population-based study of low-grade gliomas and mutated isocitrate dehydrogenase 1 (IDH1)
    Rikke H. Dahlrot
    Bjarne W. Kristensen
    Jacob Hjelmborg
    Jørn Herrstedt
    Steinbjørn Hansen
    Journal of Neuro-Oncology, 2013, 114 : 309 - 317
  • [44] A population-based study of low-grade gliomas and mutated isocitrate dehydrogenase 1 (IDH1)
    Dahlrot, Rikke H.
    Kristensen, Bjarne W.
    Hjelmborg, Jacob
    Herrstedt, Jorn
    Hansen, Steinbjorn
    JOURNAL OF NEURO-ONCOLOGY, 2013, 114 (03) : 309 - 317
  • [45] Develop mutant isocitrate dehydrogenase 1 (IDH1)-expressing gliomas using RCAS/tv-a technology
    Kim, Youngmi
    Lindberg, Nanna
    Bolouri, Hamid
    Delrow, Jeffrey
    Ozawa, Tatsuya
    Holland, Eric
    CANCER RESEARCH, 2014, 74 (19)
  • [46] Isocitrate dehydrogenase 1 (IDH1) driven Intrahepatic Cholangiocarcinoma (IHCC): A Comprehensive Genomic Profiling (CGP) Study
    Hemmerich, Amanda
    Killian, J. Keith
    Lechpammer, Mirna
    Lin, Douglas
    Danziger, Natalie
    Huang, Richard
    Decker, Brennan
    Janovitz, Tyler
    Mata, Douglas
    Elvin, Julia
    Ramkissoon, Shakti
    McGregor, Kimberly
    Ross, Jeffrey
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 970 - 971
  • [47] Mutant isocitrate dehydrogenase 1 (IDH1) inhibitor synergistically prolongs animal survival with standard therapies in patient-derived IDH1 mutant glioma xenograft mouse models
    Kogiso, Mari
    Qi, Lin
    Zhang, Huiyuan
    Braun, Frank K.
    Du, Yuchen
    Huang, Yulun
    Lindsay, Holly
    Zhao, Sibo
    Injac, Sarah G. G.
    Liu, Zhen
    Baxter, Patricia A.
    Su, Jack M.
    Perlaky, Laszlo
    Parsons, D. Williams
    Chintagumpala, Murali
    Adesina, Adekunle
    Wang, Jialiang
    Song, Yongcheng
    Li, Xiao-Nan
    CANCER RESEARCH, 2017, 77
  • [48] CLONING AND CHARACTERIZATION OF THE GENE ENCODING THE IDH1 SUBUNIT OF NAD+-DEPENDENT ISOCITRATE DEHYDROGENASE FROM SACCHAROMYCES-CEREVISIAE
    CUPP, JR
    MCALISTERHENN, L
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (23) : 16417 - 16423
  • [49] An acidic residue buried in the dimer interface of isocitrate dehydrogenase 1 (IDH1) helps regulate catalysis and pH sensitivity
    Luna, Lucas A.
    Lesecq, Zachary
    White, Katharine A.
    Hoang, An
    Scott, David A.
    Zagnitko, Olga
    Bobkov, Andrey A.
    Barber, Diane L.
    Schiffer, Jamie M.
    Isom, Daniel G.
    Sohl, Christal D.
    BIOCHEMICAL JOURNAL, 2020, 477 (16) : 2999 - 3018
  • [50] ISOCITRATE DEHYDROGENASE 1 (IDH1) MUTATIONS IN GFAP: V12HA-RAS MOUSE GLIOMA MODEL
    Sabha, Nesrin S.
    Agnihotri, Sameer
    Wolf, Amparo
    Deimling, Andreasvon
    Croul, Sidney
    Guha, Abhijit
    NEURO-ONCOLOGY, 2010, 12 : 133 - 133